The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.50
Bid: 31.00
Ask: 34.00
Change: 0.00 (0.00%)
Spread: 3.00 (9.677%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 32.50
TPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Shares / PDMR dealings / TVR

13 Dec 2021 07:00

RNS Number : 3510V
TPXimpact Holdings PLC
13 December 2021
 

 

 

13 December 2021

TPXimpact Holdings PLC (previously The Panoply)

("TPX", "TPXimpact", or the "Company")

 

Issue of Shares and PDMR dealings

 

TPXimpact Holdings PLC, the technology-enabled services company focused on digital transformation, announces that the Company has today issued 159,964 new ordinary shares of 1 pence each in respect of outstanding acquisition consideration totalling £424,780 ("Earnout Shares") and 4,627 new ordinary shares of 1 pence in respect of the Share Incentive Plan ("SIP").

 

The SIP Trustees (Cytec Trustees Limited) acquired a total of 4,627 shares (the "Partnership Shares") on 8 December 2021 at a price of £2.57 per Ordinary Share and total cost of £11,891.39 The Partnership Shares were acquired by purchase in the market and allocated to those Company employees participating in its Share Incentive Plan (SIP) scheme. As set out at the time of the announcement of TPXimpact's interim results on 30 November 2020, this SIP Plan is designed to reward and incentivise employees of the Company through tax-efficient salary sacrifice and a free matching award of Ordinary Shares on a one-for-one basis. Accordingly, on 8 December 2021, the SIP Trustees also allocated a total of 4,627 matching shares (the "Matching Shares") under the SIP. The Matching Shares are covered by the Company's block listing as announced on 15 January 2021.

 

Neal Gandhi and Oliver Rigby received Earnout Shares in respect of the acquisitions, together with Partnership Shares and Matching Shares under the SIP as follows:

 

Name

Earnout Shares issued

Partnership Shares acquired

Matching Shares issued

Total Shares post issue (including shares held by the SIP on behalf of the relevant PDMR)

Percentage of issued share capital

Neal Gandhi

33,860

58

58

8,678,035

9.9%

Oliver Rigby

0

58

58

4,226,089

4.8%

 

Remaining value of acquisition consideration to be issued

Following the issue, the Company has additional consideration to pay totalling £4,896,504. The maximum further shares to be issued as a result of this consideration is 6,149,275, which reduces to 1,813,520 assuming the share price remained constant at £2.70, being the closing mid-market price on 3 December 2021. Further details of the share issues are set out below:

 

Value £'000s

Minimum share price

Max shares to be issued '000s

Shares to be issued calculated based on price of £2.70

1,539

74p

2,078

570

1,587

82p

1,936

588

478

82.5p

580

177

1,293

83.125p

1,555

479

4,897

 

6,149

1,814

 

Timing of payment of acquisition consideration

 Value £'000s

Within the next 6 months

2,440

Between 6-12 months

1,626

After 12 months 

831

 

Admission to trading and total voting rights

 

An application has been made for the admission of the Earnout Shares to trading on AIM which is expected to take place on or around 16 December 2021. The Matching Shares are covered by the Company's block listing as announced on 15 January 2021.

 

Following this issue of Earnout Shares and Matching Shares the Company will have 87,778,511 Ordinary Shares in issue and no Ordinary Shares in treasury. Therefore, the total voting rights in TPXimpact will be 87,778,511. This figure may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries:

 

TPXimpact Holdings

Neal Gandhi (CEO)

Oliver Rigby (CFO)

 

Stifel Nicolaus Europe Limited

(Nomad and Joint Broker)

Via Alma PR

+44 (0)207 710 7600

Alex Price

Fred Walsh

 

Dowgate Capital Limited

(Joint Broker)

James Serjeant

David Poutney

 

+44 (0)203 903 7715

Alma PR 

(Financial PR)

Susie Hudson

Kieran Breheny

Matthew Young

tpx@almapr.co.uk 

+44(0)203 405 0209

 

 

 

About TPXimpact

 

TPXimpact exists to transform the organisations, services and systems that underpin society and that drive business success. It applies strategic and creative thinking, technology, innovative design and user-centred approaches to bring about numerous improvements which together multiply the impact of change. The Company works closely with its clients in agile, multidisciplinary teams that span organisational design, technology, and digital experiences. It shares a deep understanding of people and behaviours and a philosophy of putting people and communities at the heart of every transformation.

 

The business is being increasingly recognised as a leading alternative digital transformation provider to the UK public services sector, with c.75% of its client base representing the public sector and c.25% representing the commercial sector.

 

More information is available at www.tpximpact.com.

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 

Neal Gandhi

2

 

Reason for the notification

a)

Position/status

 

Chief Executive Officer

b)

Initial notification /Amendment

 

Initial notification

3

 

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

TPXimpact Holdings Plc

b)

LEI

 

2138004S9O18Q6F9MS74

4

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary Shares

Identification code

 

ISIN: GB00BGGK0V60

b)

Nature of the transaction

 

Receipt of vendor consideration shares and purchase and allocation of Partnership and Matching Shares, respectively, under TPXimpact Holdings PLC Share Incentive Plan

 

c)

Price(s) and volume(s)

 

Earnout Shares:

 

33,860 ordinary shares at 265.20p

 

Matching Shares:

 

58 ordinary shares at 257p

 

Partnership Shares:

 

58 ordinary shares at 257p

 

d)

 

 

Aggregated information

 

 

Earnout Shares:

33,860 shares

£89,797

 

- Aggregated volume

 

Matching Shares:

58 shares

£149.06

- Price

 

 

Partnership Shares:

58 shares

£149.06

e)

Date of the transaction

 

13 December 2021

f)

Place of the transaction

 

Earnout Shares and Matching Shares took place outside a trading venue

 

Partnership Shares acquired on AIM

 

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 

Oliver Rigby

2

 

Reason for the notification

a)

Position/status

 

Chief Financial Officer

b)

Initial notification /Amendment

 

Initial notification

3

 

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

TPXimpact Holdings Plc

b)

LEI

 

2138004S9O18Q6F9MS74

4

 

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary Shares

Identification code

 

ISIN: GB00BGGK0V60

b)

Nature of the transaction

 

Purchase and allocation of Partnership and Matching Shares, respectively, under TPXimpact Holdings PLC Share Incentive Plan

 

c)

Price(s) and volume(s)

 

Matching Shares:

58 ordinary shares at 257p

 

Partnership Shares:

 

58 ordinary shares at 257p

 

d)

 

 

Aggregated information

 

 

Matching Shares:

58 shares

£149.06

- Aggregated volume

 

 

Partnership Shares:

58 shares

£149.06

- Price

 

 

e)

Date of the transaction

 

13 December 2021

f)

Place of the transaction

Matching Shares took place outside a trading venue

 

Partnership Shares acquired on AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBIBDDDUBDGBG
Date   Source Headline
10th Apr 202412:25 pmRNSReplacement: Share Incentive Plan & TVR
10th Apr 20247:00 amRNSShare Incentive Plan & Total Voting Rights
8th Apr 20247:00 amRNSExercise of Options, PDMR Dealings & TVR
3rd Apr 20247:00 amRNSPDMR / PCA Shareholdings
13th Mar 20247:00 amRNSShare Incentive Plan & Total Voting Rights
7th Mar 20243:15 pmRNSHolding(s) in Company
13th Feb 20247:00 amRNSDirector Dealings, Transfer of EBT Shares & TVR
16th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSDirector/PDMR Shareholdings
10th Jan 20247:00 amRNSTransfer of shares from EBT & Total Voting Rights
9th Jan 202410:30 amRNSTPXimpact Certifies as a B Corporation
12th Dec 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
8th Dec 20237:00 amRNSExercise of Options, PDMR Dealings & TVR
5th Dec 20237:00 amRNSInterim Results
10th Nov 20231:34 pmRNSTransfer of shares from EBT & Total Voting Rights
7th Nov 20237:00 amRNSNotice of Results and Presentations
16th Oct 20237:00 amRNSH1 Trading Update & Disposal of TPXimpact Norway
12th Oct 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
28th Sep 202311:00 amRNSResult of AGM
22nd Sep 20237:00 amRNSPDMR Dealings: Grant of share options to Group CEO
18th Sep 20237:00 amRNSSale of Questers for £7.5m
14th Sep 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
5th Sep 20231:05 pmRNSUpdate on Current Trading and Notice of AGM
25th Aug 20231:03 pmRNSHolding(s) in Company
11th Aug 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
20th Jul 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
19th Jul 20233:15 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSPreliminary Results
30th Jun 20237:00 amRNSAgreement on Debt Covenants and Notice of Results
14th Jun 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
6th Jun 20237:00 amRNSIssue of Shares & Total Voting Rights
11th May 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
5th May 20237:00 amRNSTrading Statement
28th Apr 20232:35 pmRNSTotal Voting Rights
28th Apr 202310:18 amRNSContract wins
14th Apr 20235:27 pmRNSHolding(s) in Company Update
13th Apr 20237:00 amRNSTransfer of shares from EBT & Total Voting Rights
3rd Apr 20233:30 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSCovenant Waiver and Current Trading
9th Mar 20237:00 amRNSTransfer of Shares from EBT & Total Voting Rights
1st Mar 20237:00 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSIssue of Shares
16th Feb 20237:00 amRNSLTIP, PDMR Dealings & Retention Award
10th Feb 20234:31 pmRNSTransfer of shares from EBT & Total Voting Rights
9th Feb 20237:00 amRNSHolding(s) in Company
8th Feb 202312:06 pmRNSHolding(s) in Company
3rd Feb 20231:54 pmRNSDirector/PDMR Shareholding
2nd Feb 20232:45 pmRNSHolding(s) in Company
2nd Feb 20232:40 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.